Dr. Clayton D. Kazan, MD

Dr. Kazan practices at Providence Little Company of Mary Medical Center Torrance in Torrance, California, part of Providence Health & Services.

Dr. Kazan's NPI, 1245268119, was assigned on June 29, 2006. Dr. Kazan graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2001. Dr. Kazan holds California license A80682.

Dr. Kazan's primary practice is Providence Little Company of Mary Medical Center Torrance, at 4101 Torrance Blvd, Torrance, CA 90503 in Los Angeles County. The practice phone is (310) 540-7676.

Dr. Kazan's primary practice is Providence Little Company of Mary Medical Center Torrance in Torrance, California, part of Providence Health & Services. Dr. Kazan is also affiliated with St. Francis Medical Center. The medical group on file is Vituity. Dmand AI also links Dr. Kazan to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kazan practices, 2 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Kazan's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Kazan is board certified in emergency medical services by the American Board of Emergency Medicine. Dmand AI has Dr. Kazan's licenses on file in 2 states: California and Hawaii.

CMS data shows 121 Medicare services from Dr. Kazan across 4 procedure codes in 2024, for 92 Medicare patients. Medicare paid $13,236 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 92 Medicare patients who saw Dr. Kazan in 2024. The largest group is 65 to 74, with 30 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 51% are also on Medicaid. Their average risk score is 2.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kazan's median patient age at 55, with 59% women.

In 2024, Dr. Kazan wrote 51 Medicare Part D claims for 38 patients. 98% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $129 in total drug cost. In 2023, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Kazan for performance year 2024, reported as part of a group.

Dmand AI links 3 papers to Dr. Kazan, published from 2020 to 2023. Dr. Kazan's most frequent co-authors are Nichole Bosson, David Mark Shavelle, MD and Jake Toy, DO.

CMS Open Payments shows 11 general payments to Dr. Kazan from 4 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 90% of the total. Stryker Corporation paid the most, $1,166.

Dr. Kazan graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2001. Dr. Kazan is a member of ACEP and CMA.